Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1994
Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockersJ Troger, R Kirchmair, J Marksteiner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugsR Bauer, A Mayr, W Lederer, et al.
European Journal of Nuclear Medicine|October 31, 2001
Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's diseaseG Ransmayr, K Seppi, E Donnemiller, et al.
The Journal of Comparative Neurology|March 6, 1995
Evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala of the ratJ Marksteiner, E Lassnig, S Telser, et al.
Brain Research|November 5, 1990
Chromogranins in rat brain: characterization, topographical distribution and regulation of synthesisR Weiler, J Marksteiner, R Bellmann, et al.
Acta Neuropathologica|August 30, 2000
Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's diseaseJ Marksteiner, T Lechner, W A Kaufmann, et al.
Brain Research. Developmental Brain Research|June 18, 1997
Ontogenic development of secretogranin II and of its processing to secretoneurin in rat brainB Leitner, W A Kaufmann, J Marksteiner, et al.
Regulatory Peptides|August 30, 2008
Chromogranin peptides in amyotrophic lateral sclerosisA Schrott-Fischer, M Bitsche, C Humpel, et al.
Pageof 7